NSE Closed
Markets
NIFTY 5024,774.31.60%NIFTY BANK58,247.951.72%NIFTY IT31,715.253.28%NIFTY FIN SERVICE26,984.451.47%INDIA VIX11.870.94%SENSEX78,639.030.70%LT4,0252.19%ICICIBANK1,4601.71%SBIN1,0451.71%ADANIENT3,0681.94%BAJFINANCE1,1531.03%RELIANCE1,3190.86%ITC2872.14%BHARTIARTL1,970.50.08%HDFCBANK7530.65%INFY1,1804.42%TCS2,473.74.57%NIFTY 5024,774.31.60%NIFTY BANK58,247.951.72%NIFTY IT31,715.253.28%NIFTY FIN SERVICE26,984.451.47%INDIA VIX11.870.94%SENSEX78,639.030.70%LT4,0252.19%ICICIBANK1,4601.71%SBIN1,0451.71%ADANIENT3,0681.94%BAJFINANCE1,1531.03%RELIANCE1,3190.86%ITC2872.14%BHARTIARTL1,970.50.08%HDFCBANK7530.65%INFY1,1804.42%TCS2,473.74.57%
HomeSymbolREMUS

Remus Pharmaceuticals Limited

NSE · REMUS · remuspharma.com
₹766
46 (+6.39%) Today · NSE
Last close · NSE/BSE
Set alert
Fundamentals
Mkt Cap
52W High
₹952
52W Low
₹580
P/E
36.53
EPS
₹20.97
Book Value
₹276.4
ROE
ROCE
21.60%
ROA
Profit margin
Debt/Equity
P/B
2.77
Div Yield
Rev. growth
191.33%
Sector
Pharmaceuticals
Ratios
Debtor days
63.6
Inventory days
30.3
Payable days
41.9
Cash conversion
52.0
Working cap. days
93.9
Interest coverage
33.4×
Dividend payout
Technicals · Members only

Unlock the technical read on $REMUS — RSI, MACD, moving averages and intraday pivot levels — free when you sign in.

  • RSI, MACD & trend strength (ADX)
  • Price vs 20/50/100/200-day averages
  • Support & resistance pivot levels
Sign in to unlock — freeCreate an account
Premium market data is free for bulls.plus members — just sign up and verify your email. For information only — not investment advice.
Shareholding · 2026-03
Promoter 70.95%FII 5.28%DII 0.83%Public 22.93%Pledge 0.00%Shareholders 2,009
Shareholding pattern
Mar 26Sept 25Jul 25Jul 25Mar 25Sept 24Jun 24Mar 24Sept 23May 23
Promoter70.95%70.91%70.85%70.85%70.85%70.84%70.66%70.60%69.61%68.37%
FII5.28%5.02%5.03%5.03%4.77%3.16%3.00%3.25%2.38%2.55%
DII0.83%0.77%0.00%0.79%0.77%0.77%0.73%0.67%0.71%0.92%
Public22.93%23.31%24.11%23.32%23.60%25.22%25.61%25.49%27.30%28.17%
Others0.00%0.00%5.22%0.00%0.00%0.00%0.00%0.00%0.00%11.47%
No. of shareholders2,0092,0322,0172,0173981,7531,5771,1248561,743
Quarterly SEBI shareholding filings (CMOTS). Latest 10 of 12 quarters shown.
Financials
₹ CrFY25FY24FY23FY22FY21FY20
Revenue₹625.34₹217.9₹46.6₹25.44₹19.22₹12.77
EBIT₹48.8₹32.31₹11.65₹4.7₹1.44₹1.14
PBT₹47.34₹31.83₹11.41₹4.61₹1.41₹1.09
Net Profit₹29.07₹21.54₹8.5₹3.43₹1.06₹0.81
EPS (₹)₹65.21₹152.01₹83.24₹34.34₹10.6₹8.12
Figures in ₹ crore · CMOTS fundamentals via api.ipo.plus
Company details
SWAPNIL JATINBHAI SHAHChairman(Non Exe)&Dir(Non-Ind)
ARPIT DEEPAKKUMAR SHAHManaging Director
Roma Vinodbhai ShahWhole-time Director
Anar Swapnil ShahNon-Exec & Non-Independent Dir
Vishrut Chandramauli PathakIndependent Non Exe. Director
Balwant PurohitIndependent Non Exe. Director
Sanjana Sanjeev ShahIndependent Non Exe. Director
Deval PatelCompany Sec. & Compli. Officer
Corporate actions
dividend ₹0.5 (5%)Ex 2025-11-14
dividend ₹0.5 (5%)Ex 2025-09-18
bonus 1:1Ex 2025-07-04
Community sentiment · No signal
How do you feel about $REMUS? · 0 bull · 0 bear
Message volume
0
Quiet · 0 in 24h
Participation
· 0 accounts
Sentiment trend (30d)
Not enough history yet — building the sentiment trend.

$REMUS · Community

0 posts
No posts in $REMUS yet. Start the conversation.